---
title: "Daré Bioscience DARE-HPV program advances with non-dilutive US government funding"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296233050.md"
description: "Daré Bioscience announced that its DARE-HPV program for persistent high-risk HPV is advancing due to non-dilutive funding from a US government agency. The company did not disclose the specific funding amount or the name of the agency involved in this development."
datetime: "2026-08-18T13:04:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296233050.md)
  - [en](https://longbridge.com/en/news/296233050.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296233050.md)
generator: "portal-rs"
---

# Daré Bioscience DARE-HPV program advances with non-dilutive US government funding

-   Daré Bioscience said its DARE-HPV program for persistent high-risk HPV is advancing with non-dilutive government funding. \* The company did not disclose the funding amount or the agency. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608180902PRIMZONEFULLFEED9811629) on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DARE.US](https://longbridge.com/en/quote/DARE.US.md)

## Related News & Research

- [Daré Bioscience CEO presents at Virtual Investor “Why Now” on-demand series](https://longbridge.com/en/news/297190956.md)
- [Dare Bioscience Reports Q2 2026 Results: Full Earnings Call Transcript](https://longbridge.com/en/news/295850563.md)
- [NeOnc Technologies issues warrants for 3,571,430 shares in USD 15 million registered direct offering](https://longbridge.com/en/news/298454515.md)
- [Lexaria Bioscience warrants exercised at reduced price of USD 12.92 per share](https://longbridge.com/en/news/298315424.md)
- [Focus Universal says warrant exercise raises USD 3.72 million, issues 279,330 shares](https://longbridge.com/en/news/298316600.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**